Elanco

Ticks. Fleas. Intestinal Worms. Oh my! We connected with veterinary expert, Dr. Lindsay Starkey, veterinary parasitologist and an assistant professor at Auburn University and board member of the American Heartworm Society, to ask her about one of the most common parasite misconceptions. #WeAreElanco #PetHealth #GoBeyond

Scrappy, true to his name, is a fighter. This 9-year-old Yorkshire Terrier-Chihuahua mix suffered from itching to the point he lost a significant amount of fur, he didn’t want to play or go on walks and no one was getting a good night’s rest. After using Zenrelia™ (ilunocitinib tablets), his itch level improved. After just eight weeks, Scrappy was back to being a normal dog – his hair is re-growing, he’s taking long walks and most importantly, Scrappy is happy. Learn more about how dogs can reach for Zen at Zenrelia.com. IMPORTANT SAFETY INFORMATION See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://lnkd.in/gsYNzUhM. WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.

"....make the impossible possible." "...small but mighty team." "...figure out any problem and make Elanco better in the process.” For #EmployeeAppreciationDay, we asked our team to share what they love about their coworkers, and did they deliver. And THAT’S what we as a company love about our team. They constantly go beyond to deliver - for each other, our mission and above all, the world’s animals. We can't express it better than Rebecca in Customer Support who said, "From the bottom of my heart, thank you, thank you, thank you! You're the best!" Heck yeah, they are, Rebecca. And right back at you. #WeAreElanco #GoBeyond

What happens at #WVC2025… fuels the future of veterinary medicine. From a peaceful zen garden to a 10-foot tapeworm, puppy playtime and in-booth education sessions, we brought the perfect mix of innovation and fun to Las Vegas for the Western Veterinary Conference, one of the largest and longest running veterinary conferences in the country. But beyond the excitement, we showed how we’re stacking the deck for veterinarians, pet owners and pets alike with impactful solutions designed to make a real difference. Because when we push the boundaries of what’s possible, our pets and the people who care for them win big! #WeAreElanco #GoBeyond #Innovation

A dog’s sense of smell is about 10,000 to 100,000 times more powerful than a human’s. While your dog may use this superpower to find a chip under the couch, some dogs, like those with Escuela de Salvamento y Detección con Perros (ESDP), use it to save lives. Our Elanco Iberia team – a partner of ESDP – learned more about their program work of creating comprehensive training plans for canine guides specializing in locating missing persons in diverse environments, including wilderness, rubble and water. The ESDP team emphasize teamwork and canine welfare to develop highly skilled K9 units ready for real-world deployments, including working with UN agencies on disaster relief and humanitarian aid efforts around the world. Our partnership with ESDP is part of the Dejemos Huella (Let’s Leave a Mark) program, organized by the Elanco Iberia team. For more than 25 years, alongside 22 dedicated NGOs across Spain and Portugal, this program has strengthened the ties between people and animals through animal-assisted intervention programs and causes such as adoption, responsible pet ownership and combating animal abandonment. #WeAreElanco #GoBeyond

The eggs for your breakfast. The milk in your coffee. The protein on your plate. Every meal starts with a food system that depends on healthy animals. Lately, rising costs and shortages have made it clear how a resilient food system starts with healthy animals. When livestock diseases spread, the impacts ripple through the entire food chain, affecting availability, sustainability and the price we all pay in the grocery store. The good news? Innovation and collaboration in animal health is making a difference and can help curb disease spread, which is the goal of our partnership with Medgene to commercialize a highly pathogenic avian influenza vaccine for use in dairy cattle. But there’s more to be done. In a recent op-ed with Reuters, Carel du Marchie Sarvaas, Executive Director of HealthforAnimals, shares how we can build a stronger, more resilient food system, “Improving the health of food-producing animals is a ‘triple win’ with benefits for food security, economic growth and emissions reductions. Healthy animals mean a healthy, sustainable agrifood sector that supports healthy lives and livelihoods.” https://reut.rs/4imSg6V #HealthyAnimals #SustainableAgriculture

Our innovation pipeline is flowing. With six potential blockbuster products now launched, we’re positioned to accelerate into 2025. Jeff Simmons, President and CEO, recently joined Oliver Renick and the Schwab Network to discuss our latest earnings report and our partnership with Medgene, a US-based vaccine company, to commercialize a highly pathogenic avian influenza vaccine for use in dairy cattle. Check out the full conversation to hear how our team is committed to pushing beyond boundaries and setting new standards in animal health. #WeAreElanco #GoBeyond

For most of his life, Hunter hunted for itch relief but to no avail. That is until he found Zenrelia™ (ilunocitinib tablets). Hunter, an eight-year-old Chocolate lab, suffered from dermatitis and as he got older, his symptoms - especially licking at his feet and lower legs had only grown worse. He and his pet parent, Cristy, tried everything her veterinarian recommended – injections every 3-4 weeks, medicated shampoos and wipes, over the counter antihistamines, and some years when he was worse, steroids. Even with this intensive routine his symptoms were never fully controlled—until Hunter took Zenrelia. “It’s such a relief that he has relief,” said Cristy. Learn more about how dogs can reach for Zen at Zenrelia.com IMPORTANT SAFETY INFORMATION See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://lnkd.in/gsYNzUhM. WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.

It’s an exciting day as we continue to strengthen our diverse dairy portfolio and bring forward animal health solutions that help dairy and poultry farmers, while working to improve egg prices for consumers. Today, we announced an agreement with South Dakota-based Medgene to commercialize a highly pathogenic avian influenza (HPAI) vaccine for use in dairy cattle. Medgene reports the vaccine has met all requirements of U.S. Department of Agriculture’s (USDA’s) platform technology guidelines and is in the final stages of review for conditional license approval. Medgene has existing vaccine supply ready to support the U.S. dairy industry upon approval. A cattle vaccine can slow the virus spread, not just supporting our dairy farmer customers, but curbing disease spread for our poultry producers and working to improve egg prices for consumers. Read more about our announcement here: https://bit.ly/41teHS6 #WeAreElanco #GoBeyond

We’re entering 2025 with confidence, achieving our sixth consecutive quarter of organic constant currency revenue growth! Today, we reported fourth quarter and full year 2024 earnings results demonstrating accelerating momentum across our portfolios and global reach. Our innovation-driven strategy is paying off: with six potential blockbuster products now launched, we're on track to exceed expectations, generating $640-720M in revenue from these innovations in 2025. The Q4 and full-year results highlight the value of our comprehensive portfolio approach and the resilience of our diversified business. Stabilization in our core business, combined with outperforming innovation revenue, fuels our confidence in continued acceleration throughout 2025- reaffirming our outlook for 4-6% organic constant currency revenue growth. A huge thank you to our global teams for their continued focus and commitment to our customers. We are well-positioned to deliver in this new era of growth and innovation for Elanco! Read the full press release, https://bit.ly/4gRgmWh